All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
Monkeypox and Homeopathic Treatment: AAHP’s Position
AAHP notes there is no homeopathic literature, homeopathic proving, nor clinical trial which adequately supports a homeopathic drug for use as PROPHYLAXIS (or for prevention)...
Pharmacy Spotlight: Don Summerfield of Medly Pharmacy
What are consumers looking for from homeopathy today? As manufacturers, how can we best serve them? An excellent way to get a pulse on our...
Homeopathic Promoters to Note FTC is Revising its Guide on Endorsements and Testimonials
By Mark Land, AAHP President Of the thousands of homeopathic products in the marketplace, few are ever seen advertised on television - historically, the mass...
Your NDC Numbers are About to Change
By Eric Foxman, AAHP Secretary FDA has published a proposal that will change the required National Drug Code (NDC) format from 10 to 12 digits....
This Year’s AAHP Summit On Hold Until 2023
Now in its fourth year, the AAHP Summit series has gathered the industry for feedback while the HPCUS works through five compliance gaps that challenge...
A Quick Look Back: 100 Years of AAHP
By Eric Foxman, Pharm. (Ret.), AAHP Secretary A hundred years ago the homeopathic industry was, not surprisingly, vastly different. There was no industrial production, and...
House and Senate Advance FDA User Fee Reauthorization Bills
By Pete Evich In the month of June, both the House and Senate advanced separate pieces of legislation that reauthorize FDA's prescription drug, medical device,...
